{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:31:19Z","timestamp":1759336279074,"version":"3.41.2"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.pharep.2015.10.010","type":"journal-article","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T06:40:28Z","timestamp":1447137628000},"page":"415-422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The influence of aripiprazole and olanzapine on the anxiolytic-like effect observed in prenatally stressed rats (animal model of schizophrenia) exposed to the ethyl alcohol"],"prefix":"10.1007","volume":"68","author":[{"given":"Piotr","family":"Ratajczak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Kus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Giermaziak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"Nowakowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"4","key":"10.1016\/j.pharep.2015.10.010_bib0295","first-page":"615","article-title":"Associative processes disorders in schizophrenia (in Polish)","volume":"XXXVII","author":"Pers","year":"2003","journal-title":"Psychiatr Pol"},{"key":"10.1016\/j.pharep.2015.10.010_bib0300","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.neulet.2009.12.071","article-title":"Dysfunction of dopamine release in the prefrontal cortex of dysbindin deficient sandy mice: an in vivo microdialisis study","volume":"470","author":"Nagai","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharep.2015.10.010_bib0305","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1046\/j.1471-4159.2003.01873.x","article-title":"Repeated variable prenatal stress alters pre- and postsynaptic gene expression in the rat frontal pole","volume":"86","author":"Kuneninn","year":"2003","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/j.pharep.2015.10.010_bib0310","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bbr.2004.05.030","article-title":"Prenatalexposure to a repeated variable stress paradigm elicits behavioral and neuroendocrinological changes in the adult offspring:potential relevance to schizophrenia","volume":"156","author":"Koenig","year":"2005","journal-title":"Behav Brain Res"},{"issue":"2","key":"10.1016\/j.pharep.2015.10.010_bib0315","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0893-133X(01)00396-7","article-title":"Glucocorticoid hormones and early brain development in schizophrenia","volume":"27","author":"Koenig","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pharep.2015.10.010_bib0320","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S1734-1140(13)70961-7","article-title":"Influence of aripiprazole and olanzapine on behavioral dysfunctions of adolescent rats exposed to stress in perinatal period","volume":"65","author":"Ratajczak","year":"2013","journal-title":"Pharmacol Rep"},{"issue":"4","key":"10.1016\/j.pharep.2015.10.010_bib0325","doi-asserted-by":"crossref","first-page":"472","DOI":"10.55782\/ane-2013-1953","article-title":"Animal models of schizophrenia: developmental preparation in rats","volume":"73","author":"Ratajczak","year":"2013","journal-title":"Acta Neurobiol Exp (Wars)"},{"issue":"12","key":"10.1016\/j.pharep.2015.10.010_bib0330","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1055\/s-0032-1327701","article-title":"The effect of ethyl alcohol on the function of spatial memory in rats","volume":"62","author":"Ratajczak","year":"2012","journal-title":"Arzneimittelforschung"},{"issue":"3","key":"10.1016\/j.pharep.2015.10.010_bib0335","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.pharep.2013.12.008","article-title":"The influence of aripiprazole: olanzapine and enriched environment on depressant-like behavior, spatial memory dysfunction and hippocampal level of BDNF in prenatally stressed rats","volume":"66","author":"Nowakowska","year":"2014","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2015.10.010_bib0340","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jschbul\/sbi001","article-title":"Neurocognition, symptomatology and functional skills in order alcohol-abusing schizophrenia patients","volume":"31","author":"Bowie","year":"2005","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pharep.2015.10.010_bib0345","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00008877-199601000-00001","article-title":"Phencyclidine-induced stereotyped behaviour and social isolation in rats: a possible animal model of schizophrenia","volume":"7","author":"Sams-Dodd","year":"1996","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pharep.2015.10.010_bib0350","first-page":"88","article-title":"Schizophrenia and drug dependence \u2013 a case of dual diagnosis","volume":"14","author":"Sz\u0142apa-Zalewska","year":"2005","journal-title":"Post\u0119p Psychiatr Neurobiol"},{"key":"10.1016\/j.pharep.2015.10.010_bib0355","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.1990.03450190043026","article-title":"Comorbidity of mental disorders with alcohol and other drug abuse","volume":"264","author":"Regier","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.pharep.2015.10.010_bib0360","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1192\/bjp.182.2.129","article-title":"Impact of comorbid personality disorder on violence in psychosis: report from the UK700 trial","volume":"182","author":"Moran","year":"2003","journal-title":"Br J Psychiatry"},{"issue":"1","key":"10.1016\/j.pharep.2015.10.010_bib0365","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0920-9964(94)90011-6","article-title":"Substance abuse in psychotic disorders: associations with affective syndromes","volume":"14","author":"Strakowski","year":"1994","journal-title":"Schizophr Res"},{"issue":"1","key":"10.1016\/j.pharep.2015.10.010_bib0370","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/alcalc\/agh010","article-title":"Effect of naltrexone administration on short-term memory in chronically ethanol-treated outbred rats","volume":"39","author":"Okulicz-Kozaryn","year":"2004","journal-title":"Alcohol Alcohol"},{"issue":"1","key":"10.1016\/j.pharep.2015.10.010_bib0375","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ajmg.b.30194","article-title":"Direct genomic PCR sequencing of the high affinity thiamine transporter (SLC19 A2) gene identifies three genetic variants in Wernicke Korsakoff syndrome (WKS)","volume":"137B","author":"Guerrini","year":"2005","journal-title":"Am J Med Genet B: Neuropsychiatr Genet"},{"key":"10.1016\/j.pharep.2015.10.010_bib0380","doi-asserted-by":"crossref","first-page":"123","DOI":"10.31887\/DCNS.2002.4.3\/tsteimer","article-title":"The biology of fear- and anxiety-related behaviors","volume":"4","author":"Steimer","year":"2002","journal-title":"Dialogues Clin Neurosci"},{"issue":"4","key":"10.1016\/j.pharep.2015.10.010_bib0385","doi-asserted-by":"crossref","first-page":"495","DOI":"10.31887\/DCNS.2011.13.4\/tsteimer","article-title":"Animal models of anxiety disorders in rats and mice: some conceptual issues","volume":"13","author":"Steimer","year":"2011","journal-title":"Dialogues Clin Neurosci"},{"issue":"2","key":"10.1016\/j.pharep.2015.10.010_bib0390","first-page":"63","article-title":"Practical aspects of pharmacotherapy of anxiety \u2013 is there a place for Opipramol","volume":"10","author":"\u015awi\u0119cicki","year":"2013","journal-title":"Psychiatria"},{"year":"1987","series-title":"L\u0119k","author":"K\u0119pi\u0144ski","key":"10.1016\/j.pharep.2015.10.010_bib0395"},{"key":"10.1016\/j.pharep.2015.10.010_bib0400","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0924-977X(94)90002-7","article-title":"New animals models of anxiety","volume":"4","author":"Olivier","year":"1994","journal-title":"Eur Neuropsychopharm"},{"key":"10.1016\/j.pharep.2015.10.010_bib0405","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0893-133X(99)00046-9","article-title":"The role of serotonin in antipsychotic drug action","volume":"21","author":"Meltzer","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.pharep.2015.10.010_bib0410","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S1734-1140(11)70605-3","article-title":"Influence of aripiprazole on the antidepressant: anxiolytic and cognitive functions of rats","volume":"63","author":"Burda","year":"2011","journal-title":"Pharmacol Rep"},{"issue":"3","key":"10.1016\/j.pharep.2015.10.010_bib0415","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.euroneuro.2004.11.005","article-title":"Effect of chronic olanzapine treatment on nerve growth factor and brain-derived neurotrophic factor in the rat brain","volume":"15","author":"Angelucci","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharep.2015.10.010_bib0420","first-page":"295","article-title":"Influence of olanzapine on cognitive functions and catalepsy in rats after single and chronic administration","volume":"51","author":"Nowakowska","year":"1999","journal-title":"Pol J Pharmacol"},{"issue":"9","key":"10.1016\/j.pharep.2015.10.010_bib0425","doi-asserted-by":"crossref","first-page":"924","DOI":"10.4088\/JCP.13m08843","article-title":"Effectiveness of aripiprazole, olanzapine, quetiapine, and risperidone augmentation treatment for major depressive disorder: a nationwide population-based study","volume":"75","author":"Lin","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharep.2015.10.010_bib0430","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/01.jcp.0000248620.34541.bc","article-title":"An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorder","volume":"27","author":"Menza","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharep.2015.10.010_bib0435","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jad.2004.11.007","article-title":"Treatment of residual anxiety symptoms with adjunctive aripiprazole in depressed patients taking selective serotonin reuptake inhibitors","volume":"86","author":"Adson","year":"2005","journal-title":"J Affect Disord"},{"issue":"5","key":"10.1016\/j.pharep.2015.10.010_bib0440","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/00023210-200822050-00002","article-title":"Aripiprazole in the treatment of depressive and anxiety disorders: a review of current evidence","volume":"22","author":"Pae","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharep.2015.10.010_bib0445","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2008.06.100","article-title":"Aripiprazole inhibits marble-burying behavior via 5-hydroxytryptamine (5-HT)1 A receptor-independent mechanisms","volume":"592","author":"Egashira","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2015.10.010_bib0450","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neulet.2008.04.017","article-title":"Olanzapine counteracts stress-induced anxiety-like behavior in rats","volume":"438","author":"Locchi","year":"2008","journal-title":"Neurosci Lett"},{"issue":"2\u20133","key":"10.1016\/j.pharep.2015.10.010_bib0455","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0014-2999(98)00285-4","article-title":"Clozapine and olanzapine treatment decreases rat cortical and limbic GABA(A) receptors","volume":"349","author":"Farnbach-Pralong","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2015.10.010_bib0460","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.schres.2006.11.009","article-title":"The effects of antipsychotic drugs on GABA(A) receptor binding depend on period of drug treatment and binding site examined","volume":"90","author":"Skilbeck","year":"2007","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pharep.2015.10.010_bib0465","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0893-133X(97)00112-7","article-title":"Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence","volume":"18","author":"Arnt","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharep.2015.10.010_bib0470","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0306-4530(02)00049-5","article-title":"Olanzapine's effects to reduce fear and anxiety and enhance social interactions coincide with increased progestin concentrations of ovariectomized rats","volume":"28","author":"Frye","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharep.2015.10.010_bib0475","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0091-3057(96)00064-0","article-title":"Effects of typical and atypical antipsychotic drugs on freezing behavior induced by conditioned fear","volume":"55","author":"Inoue","year":"1996","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharep.2015.10.010_bib0480","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1192\/S0007125000298061","article-title":"Behavioural pharmacology of the new generation of antipsychotic agents","author":"Moore","year":"1999","journal-title":"Br J Psychiatry Suppl"},{"issue":"Suppl. 8","key":"10.1016\/j.pharep.2015.10.010_bib0485","first-page":"13","article-title":"Use of atypical antipsychotics in refractory depression and anxiety","volume":"66","author":"Nemeroff","year":"2005","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.pharep.2015.10.010_bib0490","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/01480545.2013.851687","article-title":"Evaluation of the antidepressant: anxiolytic and memory-improving efficacy of aripiprazole and fluoxetine in etanol-treated rats","volume":"37","author":"Burda-Malarz","year":"2014","journal-title":"Drug Chem Toxicol"},{"key":"10.1016\/j.pharep.2015.10.010_bib0495","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0920-9964(03)00050-1","article-title":"Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials","volume":"61","author":"Marder","year":"2003","journal-title":"Schizophr Res"},{"issue":"9","key":"10.1016\/j.pharep.2015.10.010_bib0500","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1111\/j.1530-0277.2007.00445.x","article-title":"Drug challenges reveal differences in mediation of stress facilitation of voluntary alcohol drinking and withdrawal-induced anxiety in alcohol-preferring P rats","volume":"31","author":"Overstreet","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pharep.2015.10.010_bib0505","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/sj.npp.1300917","article-title":"The effect of olanzapine on craving and alcohol consumption","volume":"31","author":"Hutchison","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pharep.2015.10.010_bib0510","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1073\/pnas.012464099","article-title":"Evidence of positive selection acting at the human dopamine receptor D4 gene locus","volume":"99","author":"Ding","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharep.2015.10.010_bib0515","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s002130000629","article-title":"Olanzapine reduces urge to drink after drinking cues and a priming dose of alcohol","volume":"155","author":"Hutchison","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharep.2015.10.010_bib0520","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1038\/sj.npp.1300264","article-title":"Olanzapine reduces craving for alcohol: a DRD4 VNTR polymorphism by pharmacotherapy interaction","volume":"28","author":"Hutchison","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pharep.2015.10.010_bib0525","first-page":"61","article-title":"Azapirones for generalized anxiety disorder","volume":"2006","author":"Chessick","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.pharep.2015.10.010_bib0530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-006-0389-0","article-title":"Reducion in repeated ethanol-withdraw-induced anxiety-like behavior by site-selective injections of 5-HTlA and 5-HT2C ligands","volume":"187","author":"Overstreet","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.pharep.2015.10.010_bib0535","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0197-0186(01)00079-1","article-title":"Tandospirone potentiates the fluoxetine-induced increases in extracellular dopamine via 5-HT (1A) receptors in the rat medial frontal cortex","volume":"40","author":"Yoshino","year":"2002","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pharep.2015.10.010_bib0540","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/dev.20444","article-title":"High ethanol dose during early adolescence induces locomotor activation and increases subsequent ethanol intake during late adolescence","volume":"52","author":"Acevedo","year":"2010","journal-title":"Dev Psychobiol"},{"issue":"4","key":"10.1016\/j.pharep.2015.10.010_bib0545","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2174\/1874473711003040205","article-title":"Behavioral and neurochemical studies in distinct animal models of ethanol's motivational effects","volume":"3","author":"Camarini","year":"2010","journal-title":"Curr Drug Abuse Rev"},{"issue":"1","key":"10.1016\/j.pharep.2015.10.010_bib0550","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s002130100741","article-title":"Reliability and validity of alcohol-induced heart rate increase as a measure of sensitivity to the stimulant properties of alcohol","volume":"57","author":"Conrod","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharep.2015.10.010_bib0555","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bbr.2014.02.032","article-title":"Relationship between ethanol-induced activity and anxiolysis in the open field, elevated plus maze, light-dark box, and ethanol intake in adolescent rats","volume":"265","author":"Acevedo","year":"2014","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharep.2015.10.010_bib0560","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1530-0277.1993.tb00785.x","article-title":"Potential role of 5HT1C and\/or 5HT2 in the mianserin-induced prevention of anxiogenic behaviors occurring during ethanol withdrawal","volume":"17","author":"Lal","year":"1993","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pharep.2015.10.010_bib0565","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1111\/j.1530-0277.2001.tb02174.x","article-title":"Effects of abstinence on the brain: quantitative magnetic resonance imaging and magnetic resonance spectroscopic imaging in chronic alcohol abuse","volume":"25","author":"O\u2019Neill","year":"2001","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pharep.2015.10.010_bib0570","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0091-3057(82)90026-0","article-title":"Regional levels of monoamines in alcohol-preferring and non-preferring lines of rats","volume":"16","author":"Murphy","year":"1982","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharep.2015.10.010_bib0575","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1093\/ajhp\/61.22.2380","article-title":"Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 2 Clinical reviews","volume":"15","author":"Kenna","year":"2004","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.pharep.2015.10.010_bib0580","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2147\/NDT.S976","article-title":"Role of endocannabinoids in regulating drug dependence","volume":"3","author":"Parolaro","year":"2007","journal-title":"Neuropsychiatr Dis Treat"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114015003473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114015003473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:36:19Z","timestamp":1752611779000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2015.10.010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1734114015003473"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2015.10.010","relation":{},"ISSN":["1734-1140"],"issn-type":[{"type":"print","value":"1734-1140"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The influence of aripiprazole and olanzapine on the anxiolytic-like effect observed in prenatally stressed rats (animal model of schizophrenia) exposed to the ethyl alcohol","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2015.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}